Key facts
- SocialRx’s last known valuation is $9.0M (Mar 2022).
- It has raised $10.8M across 1 recorded rounds; the latest was Seed Round ($649K) in Dec 2023.
- Notable investors include Service Provider Capital, One Mind, IDEA Fund Partners, Headstream, Healthworx Accelerator — 8 tracked in total.
- SocialRx has filed 1 Form D with the SEC, most recently Jan 2024 ($649K sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for SocialRx
Funding rounds
1 roundsAbout SocialRx
Developer of a digital referral and engagement-based healthcare platform designed for connecting individuals with arts and cultural experiences to support mental and emotional well-being. The company's platform facilitates access to both receptive and participatory arts programs, such as museum visits, performances, dance classes, and open mic events, through partnerships with cultural organizations, enabling healthcare providers to offer non-clinical interventions that address social isolation, anxiety, and depression in youth and older adults.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2022
- Employees
- 20
- Website
- socialrx.com/
- Ownership
- Privately Held (backing)
SocialRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SocialRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SocialRx in its N-PORT filings yet. We sweep new filings monthly.